Minneapolis Minnesota based Vergent Bioscience is raising $22,090,063.00 in New Equity Investment.
Minneapolis, MN – According to filings with the U.S. Securities and Exchange Commission, Vergent Bioscience is raising $22,090,063.00 in new funding. Sources indicate as part of senior management President and Chief Executive Officer, John Santini…